SGEN Seagen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SGEN

Price (delayed)

$159.075

Market cap

$28.94B

P/E Ratio

46.24

Dividend/share

N/A

EPS

$3.44

Enterprise value

$28.59B

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington , is ...

Highlights
The company's revenue has surged by 135% YoY and by 4.9% QoQ
SGEN's gross profit has soared by 130% year-on-year and by 4% since the previous quarter
The quick ratio has soared by 55% YoY but it has decreased by 11% QoQ
SGEN's debt is up by 6% since the previous quarter but it is down by 2.7% year-on-year
The net income has decreased by 10% from the previous quarter
The EPS has decreased by 9% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: IMGN BIIB CLDX SPPI

Key stats

What are the main financial stats of SGEN
Market
Shares outstanding
181.93M
Market cap
$28.94B
Enterprise value
$28.59B
Valuations
Price to earnings (P/E)
46.24
Price to book (P/B)
8.51
Price to sales (P/S)
12.12
EV/EBIT
47.71
EV/EBITDA
42.44
EV/Sales
11.99
Earnings
Revenue
$2.38B
EBIT
$599.3M
EBITDA
$673.67M
Free cash flow
$756.48M
Per share
EPS
$3.44
Free cash flow per share
$4.16
Book value per share
$18.69
Revenue per share
$13.12
TBVPS
$18.75
Balance sheet
Total assets
$3.95B
Total liabilities
$560.88M
Debt
$61.93M
Equity
$3.39B
Working capital
$2.66B
Liquidity
Debt to equity
0.02
Current ratio
7.14
Quick ratio
6.53
Net debt/EBITDA
-0.52
Margins
EBITDA margin
28.3%
Gross margin
88.2%
Net margin
25.1%
Operating margin
24.8%
Efficiency
Return on assets
16%
Return on equity
19%
Return on invested capital
27.1%
Return on capital employed
17%
Return on sales
25.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SGEN stock price

How has the Seagen stock price performed over time
Intraday
-2.11%
1 week
-3.6%
1 month
-4.64%
1 year
-16.5%
YTD
-9.17%
QTD
0.76%

Financial performance

How have Seagen's revenue and profit performed over time
Revenue
$2.38B
Gross profit
$2.1B
Operating income
$591.15M
Net income
$597.27M
Gross margin
88.2%
Net margin
25.1%
SGEN's net margin has surged by 200% year-on-year but it is down by 14% since the previous quarter
The company's operating margin has surged by 175% YoY but it fell by 3.9% QoQ
The company's revenue has surged by 135% YoY and by 4.9% QoQ
SGEN's gross profit has soared by 130% year-on-year and by 4% since the previous quarter

Growth

What is Seagen's growth rate over time

Valuation

What is Seagen stock price valuation
P/E
46.24
P/B
8.51
P/S
12.12
EV/EBIT
47.71
EV/EBITDA
42.44
EV/Sales
11.99
The EPS has decreased by 9% QoQ
The P/E is 8% below the last 4 quarters average of 51.1
SGEN's equity has soared by 87% YoY
The price to book (P/B) is 16% less than the 5-year quarterly average of 10.4 and 13% less than the last 4 quarters average of 10.0
The company's revenue has surged by 135% YoY and by 4.9% QoQ
The P/S is 29% below the 5-year quarterly average of 17.5 and 11% below the last 4 quarters average of 13.9

Efficiency

How efficient is Seagen business performance
The ROS has soared by 200% YoY but it has decreased by 14% QoQ
The ROIC has contracted by 23% from the previous quarter
The return on assets has declined by 21% since the previous quarter
Seagen's return on equity has decreased by 21% QoQ

Dividends

What is SGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGEN.

Financial health

How did Seagen financials performed over time
SGEN's total assets has surged by 83% year-on-year
The company's total liabilities has surged by 60% YoY and by 8% QoQ
SGEN's debt is 98% smaller than its equity
SGEN's equity has soared by 87% YoY
The debt to equity has plunged by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.